acquired
Stage
1
Investors
About
Develops epigenomic tools intended for use by clinicians and researchers to analyze and interpret epigenomic information.
Explore Ellis Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.